Curt D. Haffner
Department of Medicinal Chemistry
GlaxoSmithKline Research and Development
Research Triangle Park
NC 27709
USA
Name/email consistency: high
- Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2. Haffner, C.D., Thomson, S.A., Guo, Y., Petrov, K., Larkin, A., Banker, P., Schaaf, G., Dickerson, S., Gobel, J., Gillie, D., Condreay, J.P., Poole, C., Carpenter, T., Ulrich, J. Bioorg. Med. Chem. Lett. (2010)
- N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1. Haffner, C.D., Thomson, S.A., Guo, Y., Schaller, L.T., Boggs, S., Dickerson, S., Gobel, J., Gillie, D., Condreay, J.P. Bioorg. Med. Chem. Lett. (2010)
- Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Haffner, C.D., Diaz, C.J., Miller, A.B., Reid, R.A., Madauss, K.P., Hassell, A., Hanlon, M.H., Porter, D.J., Becherer, J.D., Carter, L.H. Bioorg. Med. Chem. Lett. (2008)
- 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV. Haffner, C.D., McDougald, D.L., Reister, S.M., Thompson, B.D., Conlee, C., Fang, J., Bass, J., Lenhard, J.M., Croom, D., Secosky-Chang, M.B., Tomaszek, T., McConn, D., Wells-Knecht, K., Johnson, P.R. Bioorg. Med. Chem. Lett. (2005)
- Structure-based design of potent retinoid X receptor alpha agonists. Haffner, C.D., Lenhard, J.M., Miller, A.B., McDougald, D.L., Dwornik, K., Ittoop, O.R., Gampe, R.T., Xu, H.E., Blanchard, S., Montana, V.G., Consler, T.G., Bledsoe, R.K., Ayscue, A., Croom, D. J. Med. Chem. (2004)
